SHORT MINI-FUTURE - BIOGEN IDEC | Market Closed - Boerse Frankfurt Warrants 13:40:13 2024-05-29 EDT | ||
| 11.87 EUR | +2.15% |
|
| Current month | +0.17% | ||
| 1 month | +1.19% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-29 | 11.87 | +2.15% |
| 24-05-28 | 11.62 | +0.96% |
| 24-05-27 | 11.51 | -0.35% |
| 24-05-24 | 11.55 | +0.43% |
| 24-05-23 | 11.5 | +6.48% |
Real-time Boerse Frankfurt Warrants
Last update May 29, 2024 at 01:40 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VX06XA |
| ISIN | DE000VX06XA2 |
| Date issued | 2021-09-08 |
| Strike | 342.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.67 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.67 € |
|---|---|
| Lowest since issue | 1.8 € |
| Spread | 0.02 € |
| Spread % | 0.17% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
218.7
USD
Average target price
286.1
USD
Spread / Average Target
+30.78%
- Stock Market
- Certificates
- Certificat
